亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

Shaanxi Dasheng Chemical Tech Co., Ltd.  

API and Intermediate

搜索
公司介紹
新聞中心
  • 暫無新聞
聯(lián)系方式
  • 聯(lián)系人:Janny Lu
  • 電話:86-29-88193552
  • 郵件:sales9@dashengchemical.com
  • 傳真:86-29-88193553
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
公司檔案
公司名稱 Shaanxi Dasheng Chemical Tech Co., Ltd.
資料認證 企業(yè)資料未認證
保 證 金 ¥0.00
公司類型 個體經(jīng)營 (制造商)
所 在 地 陜西/西安市
公司規(guī)模 50-99人
注冊資本 600萬人民幣
注冊年份 2001
經(jīng)營模式 制造商
經(jīng)營范圍 API and Intermediate
銷售的產(chǎn)品 Chlorhexidine Acetate|Chlorhexidine Hydrochloride|Chlorhexidine Gluconate Solution|Polyhexamethylene biguanidine hydrochloride|Policresulen|Topiramate|Bicalutamide|Procaterol Hydrochloride|
采購的產(chǎn)品 Acetic Acid
主營行業(yè) 醫(yī)藥與生物化工 / 原料藥 / 呼吸系統(tǒng)藥     醫(yī)藥與生物化工 / 原料藥 / 消化系統(tǒng)藥     醫(yī)藥與生物化工 / 原料藥 / 消炎藥     中間體 / 醫(yī)藥中間體    
公司介紹

Shaanxi Dasheng Chemical Tech Co., Ltd.is mainly made up of Xi’an LiSheng Pharmaceutical Co., Ltd, Research Institute and Chemical Plant. It owns hundreds of highly qualified staff specializing in research, development, production and management. The company is mainly engaged in researching & producing Hi-tech pharmaceutical and chemicals, pharmaceutical materials and mediates, synthesizing new medicine, and industrializing high technology. Xi’an Lisheng Pharmaceutical Co., Ltd has passed the State Drug Administration of GMP certification and engaged in producing & marketing pharmaceutical materials.


舉報收藏 0評論 0
©2025 Shaanxi Dasheng Chemical Tech Co., Ltd. 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:14502  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |